Bard Peripheral Vascular UltraClip Dual Trigger Instrucciones De Uso página 5

maximum temperature rise of 2.3°C after 15-minutes of continuous scanning (i.e., per pulse sequence).
In non-clinical testing, the image artifact caused by the U
approximately 4-mm from the U
pulse sequence and a 3-Tesla MR system.
Non-clinical testing demonstrated that the U
with this device can be scanned safely in an MR system under the following conditions:
scanning (i.e., per pulse sequence) in the First Level Controlled Operating Mode of operation for the MR system
maximum temperature rise of 2.2°C after 15-minutes of continuous scanning (i.e., per pulse sequence).
In non-clinical testing, the image artifact caused by the U
approximately 10-mm from the U
pulse sequence and a 3-Tesla MR system.
MR image quality may be compromised if the area of interest is in the exact same area or relatively close to the position of
the Breast Tissue Marker. Therefore, optimization of MR imaging parameters to compensate for the presence of this device
may be necessary.
Warranty
will be limited to repair or replacement of the defective product, in Bard Peripheral Vascular's sole discretion or refunding
your net price paid. Wear and tear from normal use or defects resulting from misuse of this product are not covered by this
limited warranty.
TO THE EXTENT ALLOWABLE BY APPLICABLE LAW, THIS LIMITED PRODUCT WARRANTY IS IN LIEU OF ALL
OTHER WARRANTIES, WHETHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, ANY IMPLIED
WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. IN NO EVENT WILL BARD
PERIPHERAL VASCULAR BE LIABLE TO YOU FOR ANY INDIRECT, INCIDENTAL OR CONSEQUENTIAL DAMAGES
RESULTING FROM YOUR HANDLING OR USE OF THIS PRODUCT.
Some
An issue or revision date and a revision number for these instructions are included for the user's information on the last
page of this booklet. In the event 36 months have elapsed between this date and product use, the user should contact Bard
Peripheral Vascular, Inc. to see if additional product information is available.
U C
LIP ®
Dual Trigger Breast Tissue Marker Heart is expected to produce a
LTRA
LTRA
C
LIP ®
Dual Trigger Breast Tissue Marker Heart when imaged using a gradient echo
LTRA
C
LIP ®
Dual Trigger Breast Tissue Marker Venus is MR Conditional. A patient
LTRA
U C
LIP ®
Dual Trigger Breast Tissue Marker Venus is expected to produce a
LTRA
LTRA
C
LIP ®
LTRA Dual Trigger Breast Tissue Marker Venus when imaged using a gradient echo
C
LIP ®
Dual Trigger Breast Tissue Marker Heart extends
C
LIP ®
Dual Trigger Breast Tissue Marker Venus extends
3